Anastrozole [anastrozol]
- Terms
-
Alozex
Arimidex
Egistrozol
-
2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)
Anastrazole
Arimidex
ICI D1033
ZD-1033
ZD1033
Zeneca ZD 1033
A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women.
- DUI
- D000077384 MeSH Browser
- CUI
- M0238999
- CAS
- 1,3-Benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-
- History note
- 2019 (1994)
- Public note
- 2019; ANASTROZOLE was indexed under NITRILES and TRIAZOLES 1994-2018
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects 1
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 1
- PK
- pharmacokinetics 1
- PD
- pharmacology 4
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 6
- TO
- toxicity 0
- UR
- urine 0